Paul K. Wotton, President and CEO at ANTARES PHARMA, INC. (ATRS), sold 64,100 shares at $4.00 ($256K) on 2013-12-09, disclosed to the SEC on 2013-12-10.
Scheduled sale ($256k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 46,000 | $184K | 71.8% |
| 2 | $4.00 | 18,100 | $72K | 28.2% |
| Total | $4.00 avg | 64,100 | $256K | 100% |
| Filing → |
| VCEL | SELL | 2024-12-05 | $153K | — | Filing → |
| VCEL | SELL | 2023-12-15 | $187K | — | Filing → |
| VCEL | SELL | 2021-05-17 | $505K | — | Filing → |